Clinical trial
Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated…
NCT00400907 · German High-Grade Non-Hodgkin's Lymphoma Study Group, Other · Unknown status
Key facts
| NCT number | NCT00400907 |
|---|---|
| Title | Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9 |
| Official title | Follow-up Observational Study of the Randomised Intergroup Trial of First Line Treatment for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma With CHOP-Like Chemotherapy Regimen With or Without the Anti-CD20 Antibody Rituximab (IDEC-C2B8) [MINT] |
| Lead sponsor | German High-Grade Non-Hodgkin's Lymphoma Study Group, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Long-term Effects Secondary to Cancer Therapy in Adults, Lymphoma |
| Intervention type | Other, Procedure |
| Interventions | clinical observation, management of therapy complications |
| Enrollment | 667 |
| Start date | Jan 1, 2006 |
| First posted | Nov 17, 2006 |
| Last update posted | Dec 20, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: